TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes

Sharon C Hook1, Alexandra Chadt2,3, Kate J Heesom1

  • 1School of Biochemistry, Biomedical Sciences Building, University of Bristol, University Walk, Bristol, BS8 1TD, UK.

Scientific Reports
|October 22, 2020
PubMed

Insights

Researchers identified new proteins, VPS13A and VPS13C, that interact with TBC1D1 to regulate glucose transporter type 4 (GLUT4) trafficking. This discovery offers potential therapeutic targets for insulin resistance and type 2 diabetes.

Area of Science:

  • Cell biology
  • Molecular endocrinology
  • Metabolic disease research

Background:

  • Insulin resistance and type 2 diabetes are linked to impaired glucose uptake, with GLUT4 trafficking being a critical regulatory process.
  • TBC1D1 is a key protein controlling glucose uptake and GLUT4 trafficking in response to insulin and exercise.
  • Identifying TBC1D1-interacting proteins is crucial for understanding and targeting metabolic dysregulation.

Purpose of the Study:

  • To identify novel proteins that interact with TBC1D1 and regulate GLUT4 trafficking and homeostasis.
  • To investigate the role of these TBC1D1-interacting proteins in the context of insulin resistance and diabetes.

Main Methods:

  • Unbiased quantitative proteomics was employed to identify TBC1D1-interacting proteins in C2C12 myotubes.
  • Protein interactions were analyzed, focusing on associations via TBC1D1's phosphotyrosine binding (PTB) domains.
  • Gene depletion studies (VPS13A, VPS13C) were performed to assess their impact on GLUT4 levels and cell surface expression.

Main Results:

  • Proteomics identified VPS13A, VPS13C, EHBP1L1, MICAL1, and SERCA1 as TBC1D1 interactors.
  • These proteins bind to TBC1D1 via its PTB domains, independently of AMPK activation.
  • Depletion of VPS13A or VPS13C led to increased cellular and cell surface GLUT4 levels, specifically for GLUT4, upon AMPK activation.

Conclusions:

  • The TBC1D1 PTB domains act as a scaffold for various Rab regulators, including VPS13A and VPS13C.
  • VPS13 proteins play a significant role in regulating GLUT4 trafficking and cellular glucose uptake.
  • These findings highlight VPS13 proteins as potential therapeutic targets for managing insulin resistance and type 2 diabetes.

Related Concept Videos

Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
9.1K
Vesicular Tubular Clusters01:45

Vesicular Tubular Clusters

After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
2.9K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.2K
Transport Across the Golgi01:26

Transport Across the Golgi

While it is unclear how molecules move between adjacent Golgi cisternae, it is apparent that the molecules move from cis- cisterna, the entry face, to the trans- cisterna, the exit face. Experiments initially suggested vesicles that bud from one cisterna and fuse with the next cisterna to transport proteins between the cisternae. This vesicular transport model describes the Golgi apparatus as a relatively static structure with a unique enzyme composition in each cisterna. Molecules are...
5.5K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K